Moxonidine (Compound)

Synonyms:MOXONIDINE, 75438-57-2, Norcynt, Nucynt, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine, Cynt, Physiotens, BE 5895, 4-chloro-N-imidazolidin-2-ylidene-6-methoxy-2-methylpyrimidin-5-amine, BDF5895, UNII-CC6X0L40GW, BDF 5895, Lomox, 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine, LY 326869, CC6X0L40GW, CHEMBL19236, CHEBI:7009, BDF5896, 4-Chloro-5-(2-imidazolin-2-ylamino)-6-methoxy-2-methylpyrimidine, BE-5895, 75438-57-2 (free base), BE5895, 5-Pyrimidinamine, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-, NCGC00015649-02, LY326869, Normoxocin, CAS-75438-57-2, DSSTox_CID_25170, DSSTox_RID_80720, DSSTox_GSID_45170, Moxonidinum [Latin], Moxonidina [Spanish], Moxonidina, Moxonidinum, 4-chloro-N-(imidazolidin-2-ylidene)-6-methoxy-2-methylpyrimidin-5-amine, Moxonidine hydrochloride hydrate, BDF-5895, LY-326869, Moxonidine [USAN:INN:BAN], N-(4-chloro-6-methoxy-2-methylpyrimidin-5-yl)imidazolidin-2-imine, SR-01000075981, Cynt (TN), Moxonidine (USAN/INN), Prestwick0_001016, Prestwick1_001016, Prestwick2_001016, Prestwick3_001016, Lopac-M-1559, Monoxidine [common misspelling of Moxonidine], Lopac0_000753, SCHEMBL49143, BSPBio_001171, MLS002222183, SPBio_003042, BPBio1_001289, DTXSID5045170, HMS1571K13, HMS2098K13, HMS2230B15, HMS3373O04, HMS3655B17, HMS3715K13, HMS3747A03, Moxonidine 1.0 mg/ml in Methanol, ALBB-022451, BCP23003, BDF-5896, EX-A3409, HY-B0374, ZINC1854466, Tox21_110190, 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline, 4-Chloro-5-(2-imidazolidinyldeneamino)-6-methoxy-2-methylpyrimidine, 4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine, AC-637, BDBM50050093, MFCD22689455, PDSP1_000177, PDSP2_000176, s2066, STL419983, STL450991, AKOS015895873, AKOS015997932, Tox21_110190_1, AF-0062, CCG-204838, DB09242, SDCCGSBI-0050731.P002, VA11330, NCGC00015649-01, NCGC00015649-04, NCGC00015649-05, NCGC00015649-08, NCGC00015649-17, NCGC00092355-02, K289, SMR000857402, AB0014143

Pubchem:PUBCHEM:4810

Id:4810

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Moxonidine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Moxonidine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Moxonidine.

Results found

Linked to

	Label	Description
	BRD-K77771411-001-12-7 Substance (Entity type)	A Substance
	moxonidine (4278d7ab-1c4a-4190-b649-38608407c16a) Collection (Entity type)	Metadatata for moxonidine
	DCSTRUCT ID 01856 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01856; PubChem_CID:4810, FILE=drugcentral_drug_01856.json)
	Moxonidine positively regulates CCNE2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine negatively regulates ALCAM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine negatively regulates ADGRG2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine negatively regulates FABP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine positively regulates PRKAR2B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine positively regulates DTL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxonidine negatively regulates CDC25B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS